NervGen Announces Positive Independent, Blinded Biomechanical Gait Analyses Demonstrating Genuine Neural Recovery with NVG-291 in Phase 1b/2a CONNECT SCI Study

Data ReadoutpositiveNVG-291Positive

AI Analysis

Summary

NervGen announced positive independent, blinded biomechanical gait analyses from its Phase 1b/2a CONNECT SCI study showing genuine neural recovery with NVG-291 in spinal cord injury patients.

Clinical Trial Data

Phase

1b/2a

Primary Endpoint

Met

Outcome Details

Positive independent, blinded biomechanical gait analyses demonstrating genuine neural recovery

Importance:7/10

Sentiment:

0.80

Phase 1b/2agait analysisneural recoveryspinal cord injuryCONNECT SCI

Related Companies

$NGEN

Read the original article

Published by yahoo_finance on May 26, 2026 11:15 AM

Read Original